{"transactions":[{"id":914723,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67285,"kind":"person","name":"Kline Ashley Hartmann","position":1,"cik":"0002071433","reported_name":"Kline Ashley Hartmann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2026-02-09T16:08:07.000Z","date":"2026-02-05","kind":"grant","planned":false,"acquired":true,"shares":38517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest and become exercisable in equal monthly installments over 48 months commencing from February 5, 2026, subject to the Reporting Person's continuous service through each applicable vesting date."}],"balance_after":38517,"derivative":{"exercise_price":76.43,"expiration_date":"2036-02-05","underlying":"Common Stock","underlying_shares":38517},"source":{"system":"sec-edgar","filing":"0001104659-26-012067","document":"tm265512-4_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2071433/000110465926012067/tm265512-4_4seq1.xml","form_type":"4"}},{"id":1125661,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67285,"kind":"person","name":"Kline Ashley Hartmann","position":1,"cik":"0002071433","reported_name":"Kline Ashley Hartmann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-06-03T21:15:01.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":111496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on May 27, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":111496,"derivative":{"exercise_price":22.94,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":111496},"source":{"system":"sec-edgar","filing":"0001583648-25-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2071433/000158364825000030/edgardoc.xml","form_type":"4"}},{"id":1125660,"issuer":{"id":4452,"kind":"organization","name":"PALVELLA THERAPEUTICS, INC.","symbol":"PVLA"},"owners":[{"id":67285,"kind":"person","name":"Kline Ashley Hartmann","position":1,"cik":"0002071433","reported_name":"Kline Ashley Hartmann","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Commercial Officer"}}],"security":"Incentive Stock Option (right to buy)","published_at":"2025-06-03T21:15:01.000Z","date":"2025-05-27","kind":"grant","planned":false,"acquired":true,"shares":17436,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests 25% on May 27, 2026, with the remaining 75% vesting in 36 equal monthly installments thereafter, subject to the Reporting Person's continued service with the Issuer as of each such vesting date."}],"balance_after":17436,"derivative":{"exercise_price":22.94,"expiration_date":"2035-05-26","underlying":"Common Stock","underlying_shares":17436},"source":{"system":"sec-edgar","filing":"0001583648-25-000030","document":"edgardoc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2071433/000158364825000030/edgardoc.xml","form_type":"4"}}]}